• Approach

    Learn about our collaborative models

  • Focus

    Read about our core research themes

  • Collaboration

    Learn about our key partnerships

Eisai & Charles River Laboratories Announce Collaboration

Charles River Logo

Eisai and Charles River Laboratories announced that they have signed a collaboration agreement which will see Charles River scientists work at Eisai’s research and development facilities in Hatfield, UK.

The collaboration will involve Charles River supporting Eisai scientists from Japan, USA and the UK on a range of synthetic and medicinal chemistry projects, including those seeking novel treatments for neurological diseases. This is an example of Eisai’s commitment to Open Innovation and novel collaborative working practices.

Charles River scientists will also participate in a medicinal chemistry project to discover new antimalarial drugs with activity against drug resistant strains of disease, which could potentially address this area of unmet medical need in malaria treatment. This work is in collaboration with the GHIT Fund (Global Health Innovative Technology Fund) and Medicines for Malaria Venture, and builds upon earlier research by Eisai which has focused on malaria and neglected diseases to improve access to medicines in developing countries.

InflamationNeurodegenerationGeneral MedcineGenomics